Zaza Ndhlovu, SANTHE Senior Researcher and trainee Supervisor, based at the HIV Pathogenesis Programme (HPP) at the University of KwaZulu-Natal, was recently selected to present his abstract at the 2016 CAVD (Collaboration for AIDS Vaccine Discovery) Annual Meeting, in Seattle, Washington, December 6 to 8.
The CAVD Alliance Management and HIV Vaccine Team at the Bill & Melinda Gates Foundation selected Ndhlovu’s abstract as one of six to be presented during the Norm Letvin Early Career Investigator Session at the meeting. Professor Norman Letvin was one of the pioneers of HIV research.
CAVD is an international network of scientists and experts dedicated to designing a variety of novel HIV vaccine candidates and advancing the most promising candidates to clinical trials. It operates on the principle that accelerating progress toward an AIDS vaccine requires the creativity of individual investigators supported by a collaborative approach that emphasises the sharing of scientific information and the standardisation of laboratory techniques and data analysis.
The selection of Ndhlovu’s abstract was based on merit scores and comments from a reviewing panel of 10 CAVD principal investigators who said, “We had an excellent set of applications and being chosen is a distinction.” Ndlovu said he felt honoured and privileged by the invitation.